HemoSonics, LLC Comparables
Find the most relevant public market comparables for HemoSonics, LLC, including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
HemoSonics, LLC is a medical device technology company focused on acute bleeding management, resulting in better patient care and lower overall medical costs. They develop and manufacture the Quantra Hemostasis Analyzer, a device designed to improve patient outcomes and reduce healthcare costs by providing optimized coagulation information. The Quantra System's easy and fast interpretation enables simple, more efficient point-of-care and laboratory bleeding management.
Business Model
Medical device manufacturing and sales
Target Customers
Hospitals, surgical centers, and blood banks
Specific Focus
Viscoelastic testing (VET) for acute bleeding management
Location
Durham, North Carolina
CEO
Bob Roda
Industry
Life sciences
Sub Sector
Point-of-care diagnostics
3yr Revenue Growth
234%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to HemoSonics, LLC in the Medical Devices sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for HemoSonics, LLC? Our platform provides detailed analysis of HemoSonics, LLC's competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full HemoSonics, LLC compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full HemoSonics, LLC Compset
As a leading player in the Life sciences industry within the Medical Devices sector, HemoSonics, LLC operates in the specialized Point-of-care diagnostics sub-sector. Understanding how HemoSonics, LLC compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Point-of-care diagnostics space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
TG Therapeutics, Inc.
Healthcare • Life sciences
TG Therapeutics, Inc. is a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. They have received FDA approval for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis.
Vytalize Health
Healthcare • Life sciences
Vytalize Health is a risk-bearing provider enablement platform and leading Accountable Care Organization (ACO) that partners with primary care physicians (PCPs) to deliver value-based care, improving patient outcomes and reducing healthcare costs. They offer an all-in-one solution including value-based incentives, smart technology, and a virtual clinic, enabling independent practices to thrive in value-based care arrangements. The company focuses on Medicare patients and works with over 2,500 PCPs across 36 states.
Talkiatry
Healthcare • Life sciences
Talkiatry is a national mental health practice providing in-network psychiatry and therapy via telehealth. It utilizes technology and a human-centered approach to improve access to high-quality mental healthcare, addressing issues of accessibility and affordability.
Get Your Custom Comparable Analysis
Need a more detailed analysis of HemoSonics, LLC and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free